USA Today Once Again Eats Pavement Over This Tweet About Caitlin Clark
YouTuber Ms Rachel Just Cut a Campaign Check. Take a Wild Guess of...
Dems Know They Probably Should've Kept This Poll Private, Right?
Disbarred for Defending Trump: ACLJ Takes the Fight to the Supreme Court
New York Times Puts Brutal Dictator on Its Fashion List, Then Quietly Deletes...
USA Today Gets Tripped by Its Caitlin Clark Opposition. AP Weeps We No...
Thought Crimes Come to Minnesota
Forcing Assisted Suicide Is Unconstitutional
Trump Roasts the Media, RFK Jr., and Nikki Minaj at WHCA Dinner. Here's...
Bosnian War Crimes Suspect Indicted for Lying on U.S. Citizenship Application
Whitmer Endorses Stevens Over Socialist El-Sayed in Michigan Senate Primary
Florida Financier Sentenced to 20 Years for Laundering Funds Tied to Haitian Assassination
Two Georgia Men Plead Guilty in $550,000 New York Film Tax Credit Scam
NM Woman Pleads Guilty in $3.9 Million Medicaid Transportation Fraud Scheme
Trump Demands Key 'Reconciliation 3.0' Step Passed Before August Recess
Tipsheet

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine
AP Photo/Rogelio D. Solis

Moderna announced on Thursday it had begun development for a potential single-dose vaccine that is a combination of a Wuhan coronavirus vaccine booster shot and seasonal flu shot. 

Advertisement

In a press release published Thursday, Moderna CEO Stephane Bancel announced the new development and shared the progress of other programs the company is working on, such as their “cancer vaccine.” 

“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”

As we previously reported, Moderna informed investors and analysts last month that the company was planning for a booster COVID-19 shot in addition to its already-existing two-dose mRNA vaccine shot. As of right now, the Moderna COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be administered to prevent the spread of COVID-19. However, the vaccine has not been fully approved by the FDA.

Advertisement

Related:

COVID-19 VACCINE

“We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Bancel said in a statement last month announcing plans for a potential booster shot. In the statement, Bancel also said Moderna is “looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and RSV for adults.”

Perhaps that vision could be on the horizon with this hybrid coronavirus/flu vaccine in the works. This week, however, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus reiterated his call for a halt on COVID-19 booster shots through the end of the year. Moderna has not revealed when it plans to have the booster shot completed.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement